| 常用名 | 阿齐瑞格 | CAS号 | 603148-36-3 |
|---|---|---|---|
| 价格 | 纯度 | 98.0% | |
| 备货期 | 10天 | 库存 | 现货 |
| 产品详情(用途,包装等)
用途: TTP488 is an antagonist at the Receptor for Advanced Glycation End products, is evaluated as a potential treatment for patients with mild-to-moderate Alzheimer's disease (AD).Target: RAGEin vitro: TTP488 is an orally active, centrally acting antagonist of RAGE-RAGE ligand interaction. Chronic oral dosing of TTP488 in AD transgenic mice led to a reduction of amyloid load in the brain, improves performance on behavioral testing and normalization of electrophysiological recordings from hippocampal slices.[1]in vivo: The small molecule RAGE antagonist, TTP488, is developed by Trans-Tech Pharma. The TTP488 or control peptide is administered i.p. daily at a dose of 100 mcg/d.[3] Successful use of the RAGE inhibitor TTP488 in Phase II testing has led to a Phase III clinical trial for AD patients.[2] 物理化学性质: CAS号:603148-36-3 常用中文名:阿齐瑞格 常用英文名:Azeliragon 分子式:C32H38ClN3O2 分子量:532.116 密度:1.1±0.1 g/cm3 沸点:667.7±65.0 °C at 760 mmHg 熔点:N/A 闪点:357.6±34.3 °C 储存条件:2~8°C |